SEC Form 4 · accession 0001865525-26-000024
Guardant Health, Inc. · GH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Medina Manuel Hidalgo
Director
Period of report
Aug 5, 2026
Accepted (ET)
Aug 6, 2026 · 5:06 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001576280
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 5, 2026 | M | 950 | $32.55 | A | 6,256 | D | |
| Common Stock | Aug 5, 2026 | S | 950 | $163.945 | D | 5,306 | D | |
| Common Stock | Aug 5, 2026 | S | 750 | $164.6051 | D | 4,556 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $32.55 | Aug 5, 2026 | M | 950 | D | — | Jul 17, 2034 | Common Stock | 950 | 12,079 | D |
Explanation of responses
- F1The stock option granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter.